A Study of LAD603 in Adults With Alopecia Areata

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
The main aim of the study is to evaluate the effect of LAD603 in adult participants with severe to very severe alopecia areata (AA). The study will also evaluate the safety, pharmacokinetics (PK), immunogenicity and pharmacodynamic (PD) biomarkers of LAD603.
Epistemonikos ID: ba7b121e0fc7c11261db995418aef96be001772d
First added on: Jan 01, 2026